Analysis of urinary N-acetyl-S-(propionamide)-cysteine as a biomarker for the assessment of acrylamide exposure in smokers

Environmental Research

Volumn 104, Issue 3, 2007, Pages 346-351

  Huang, Chih Chun Jean ^a   Li, Chien Ming ^a   Wu, Chia Fang ^a   Jao, Su Ping ^a   Wu, Kuen Yuh ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Acrylamide; Cotinine; Liquid chromatography coupled with tandem mass spectrometry (LC MS MS); N acetyl S (propionamide) cysteine (NASPC); Tobacco smoke

Indexed keywords

ACRYLAMIDE; ACRYLAMIDE DERIVATIVE; BIOLOGICAL MARKER; CARCINOGEN; COTININE; CYSTEINE DERIVATIVE; N ACETYL S (PROPIONAMIDE)CYSTEINE; PROPIONAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

BIOMARKER; CARCINOGEN; HEALTH MONITORING; HEALTH RISK; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SMOKING; URINE;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; HUMAN; LIQUID CHROMATOGRAPHY; MALE; METABOLITE; PRIORITY JOURNAL; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; SMOKING HABIT; SOLDIER; TAIWAN; TANDEM MASS SPECTROMETRY; URINALYSIS; VALIDATION PROCESS;

ACETYLCYSTEINE; ACRYLAMIDE; ADULT; BIOLOGICAL MARKERS; COTININE; CREATININE; HUMANS; INHALATION EXPOSURE; LINEAR MODELS; MALE; SMOKING;

NICOTIANA TABACUM;

EID: 34249813991     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2007.03.005     Document Type: Article

References (30)

1. Barr D.B., Gonzalez A.J., Caudill S.P., Needham L.L., Wilder L.C., and Pirkle J.L. Urinary creatinine concentrations in the US population: implications for urinary biologic monitoring measurements. Environ. Health Perspect. 113 2 (2005) 192-200
2. Behera D., Uppal R., and Majumdar S. Urinary levels of nicotine and cotinine in tobacco users. Indian J. Med. Res. 118 (2003) 129-133
3. Benowitz N.L. Biomarkers of environmental tobacco smoke exposure. Environ. Health Perspect. 107 Suppl. 2 (1999) 349-355
4. Bergmark E. Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers and nonsmokers. Chem. Res. Toxicol. 10 (1997) 78-84
5. Bergmark E., Calleman C.J., and Costa L.G. Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat. Toxicol. Appl. Pharmacol. 111 (1991) 352-363
6. Bergmark E., Calleman C.J., He F., and Costa L.G. Determination of hemoglobin adducts in humans occupationally exposed to acrylamide. Toxicol. Appl. Pharmacol. 120 (1993) 45-54
7. Boettcher M.I., and Angerer J. Determination of the major mercapturic acids of acrylamide and glycidamide in human urine by LC-ESI-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 824 (2005) 283-294
8. Boettcher M.I., Schettgen T., Kutting B., Pischetsrieder M., and Angerer J. Mercapturic acids of acrylamide and glycidamide as biomarkers of the internal exposure to acrylamide in the general population. Mutat. Res. 580 (2005) 167-176
9. Bull R.J., Robinson M., Laurie R.D., Stoner G.D., Greisiger E., Meier J.R., and Stober J. Carcinogenic effects of acrylamide in Sencar and A/J mice. Cancer Res. 44 (1984) 107-111
10. Calleman C.J., Bergmark E., and Costa L.G. Acrylamide is metabolized to glycidamide in the rat: evidence from hemoglobin adduct formation. Chem. Res. Toxicol. 3 (1990) 406-412
11. Calleman C.J., Wu Y., He F., Tian G., Bergmark E., Zhang S., Deng H., Wang Y., Crofton K.M., and Fennell T. Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide. Toxicol. Appl. Pharmacol. 126 2 (1994) 361-371
12. Carrieri M., Trevisan A., and Bartolucci G.B. Adjustment to concentration-dilution of spot urine samples: correlation between specific gravity and creatinine. Int. Arch. Occup. Environ. Health 74 1 (2001) 63-67
13. Ceppa F., Dupuy O., Burnat P., El Jahiri Y., and Mayaudon H. High-performance liquid chromatographic determination of cotinine in urine in isocratic mode. J. Chromatogr. B Biomed. Sci. Appl. 746 (2001) 115-122
14. Fennell T.R., Snyder R.W., Krol W.L., and Sumner S.C.J. Comparison of the hemoglobin adducts formed by administration of N-methylolacrylamide and acrylamide to rats. Toxicol. Sci. 71 (2003) 164-175
15. Fennell T.R., Burgess J., Friedman M.A., Snyder R.W., Spicer R., Sumner S.C.J., and Bridson W.E. Metabolism and hemoglobin adduct formation of acrylamide in humans. Toxicol. Sci. 85 (2005) 447-459
16. Holl R.W., Debatin K.M., Grabert M., and Heinze E. Objective assessment of smoking habits by urinary cotinine measurement in adolescents and young adults with type 1 diabetes. Reliability of reported cigarette consumption and relationship to urinary albumin excretion. Diabetes Care 21 (1998) 787-791
17. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, and National Cancer Institute (US). Some Industrial Chemicals (1994), World Health Organization, International Agency for Research on Cancer, Geneva, Switzerland
18. Li C.M., Wu K.Y., and Hu C.W. Quantification of urinary N-acetyl-S- (propionamide)cysteine using an on-line clean-up system coupled with liquid chromatography/tandem mass spectrometry. J. Mass Spectrom. 40 (2005) 511-515
19. McCollister D.D., Rowe V.K., and Oyen F. Toxicology of acrylamide. Toxicol. Appl. Pharmacol. 103 (1964) 172-181
20. McDonald S.P., Maguire G.P., and Hoy W.E. Validation of self-reported cigarette smoking in a remote Australian aboriginal community. Aust. N. Z. J. Public Health 27 (2003) 57-60
21. Mottram D.S., Wedzicha B.L., and Dodson A.T. Acrylamide is formed in the Maillard reaction. Nature 419 (2002) 448-449
22. Schettgen T., Broding H.C., Angerer J., and Drexler H. Hemoglobin adducts of ethylene oxide, propylene oxide, acrylonitrile and acrylamide-biomarkers in occupational and environmental medicine. Toxicol. Lett. 134 (2002) 65-70
23. Smith C.J., Perfetti T.A., Rumple M.A., Rodgman A., and Doolittle D.J. "IARC group 2A carcinogens" reported in cigarette mainstream smoke. Food Chem. Toxicol. 38 (2000) 371-383
24. Spencer P.S., and Schaumburg H.H. Nervous system degeneration produced by acrylamide monomer. Environ. Health Perspect. 11 (1975) 129-133
25. Stadler R.H., Blank I., Varga N., Robert F., Hau J., Guy P.A., Robert M.C., and Riediker S. Acrylamide from Maillard reaction products. Nature 419 (2002) 449-450
26. 13C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 5 (1992) 81-89
27. Sumner S.C., Fennell T.R., Selvaraj L., and Nauhaus S.K. Urinary metabolites from F344 rats and B6C3F1 mice coadministered acrylamide and acrylonitrile for 1 or 5 days. Chem. Res. Toxicol. 10 (1997) 1152-1160
28. Sumner S.C., Fennell T.R., Moore T.A., Chanas B., Gonzalez F., and Ghanayem B.I. Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. Chem. Res. Toxicol. 12 (1999) 1110-1116
29. Urban M., Kavvadias D., Riedel K., Scherer G., and Tricker A.R. Urinary mercapturic acids and a hemoglobin adduct for the dosimetry of acrylamide exposure in smokers and nonsmokers. Inhal. Toxicol. 18 (2006) 831-839
30. Wu Y.Q., Zhang J., Cui T., Yu A.R., and Tang X.Y. Determination of acrylamide metabolite, mercapturic acid by high performance liquid chromatography. Biomed. Environ. Sci. 6 (1994) 273-280